Literature DB >> 20649535

Evaluating mitochondrial DNA in cancer occurrence and development.

Lijun Shen1, Hezhi Fang, Tao Chen, Jing He, Mei Zhang, Xiaosong Wei, Yijuan Xin, Yulin Jiang, Zhinan Ding, Jingzhang Ji, Jianxin Lu, Yidong Bai.   

Abstract

Abnormal mitochondria have long been hypothesized to be involved in tumorigenesis. Mitochondrial DNA (mtDNA) mutations have been found in various cancer cells, yet their role in tumorigenesis remains largely unknown. Our long-term goal is to understand the role of mtDNA polymorphism and mtDNA mutations in tumorigenesis. We focused on the role of the mtDNA haplogroup; a 4,977 bp common mtDNA deletion; mtDNA mutations in the main control region of mtDNA or displacement loop; and mtDNA heteroplasmy in cancer occurrence and cancer development. Our results indicate that qualitative and quantitative changes in mtDNA play an important role in cancer development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20649535     DOI: 10.1111/j.1749-6632.2010.05635.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  17 in total

1.  The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population.

Authors:  Yiqi Jin; Qiang Yu; Dayong Zhou; Lei Chen; Xianchen Huang; Guoxiong Xu; Jian Huang; Xueren Gao; Yuzhen Gao; Liming Shen
Journal:  Genet Test Mol Biomarkers       Date:  2012-01-27

Review 2.  Curbing cancer's sweet tooth: is there a role for MnSOD in regulation of the Warburg effect?

Authors:  Aaron K Holley; Sanjit Kumar Dhar; Daret K St Clair
Journal:  Mitochondrion       Date:  2012-07-20       Impact factor: 4.160

3.  Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer.

Authors:  Hezhi Fang; Lijun Shen; Tao Chen; Jing He; Zhinan Ding; Jia Wei; Jianchun Qu; Guorong Chen; Jianxin Lu; Yidong Bai
Journal:  BMC Cancer       Date:  2010-08-12       Impact factor: 4.430

4.  Female-specific association among I, J and K mitochondrial genetic haplogroups and cancer: A longitudinal cohort study.

Authors:  Claudio Luchini; Alessia Nottegar; Alberto Vaona; Brendon Stubbs; Jacopo Demurtas; Stefania Maggi; Nicola Veronese
Journal:  Cancer Genet       Date:  2018-04-11

5.  Mitochondrial common deletion is elevated in blood of breast cancer patients mediated by oxidative stress.

Authors:  Hezhongrong Nie; Guorong Chen; Jing He; Fengjiao Zhang; Ming Li; Qiufeng Wang; Huaibin Zhou; Jianxin Lyu; Yidong Bai
Journal:  Mitochondrion       Date:  2015-12-08       Impact factor: 4.160

6.  Mitochondria and familial predisposition to breast cancer.

Authors:  Stefania Weigl; Angelo Paradiso; Stefania Tommasi
Journal:  Curr Genomics       Date:  2013-05       Impact factor: 2.236

7.  Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality.

Authors:  S Masuda; T Kadowaki; N Kumaki; X Tang; Y Tokuda; S Yoshimura; S Takekoshi; R Y Osamura
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

8.  The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer.

Authors:  Tao Chen; Jing He; Lijun Shen; Hezhi Fang; Hezhongrong Nie; Tao Jin; Xiaosong Wei; Yijuan Xin; Yulin Jiang; Hongzhi Li; Guorong Chen; Jianxin Lu; Yidong Bai
Journal:  BMC Med Genet       Date:  2011-01-13       Impact factor: 2.103

9.  The mitochondrial DNA Northeast Asia CZD haplogroup is associated with good disease-free survival among male oral squamous cell carcinoma patients.

Authors:  Chih-Hsiung Lai; Shiang-Fu Huang; I-How Chen; Chun-Ta Liao; Hung-Ming Wang; Ling-Ling Hsieh
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

10.  Mitochondrial common deletion, a potential biomarker for cancer occurrence, is selected against in cancer background: a meta-analysis of 38 studies.

Authors:  Hezhongrong Nie; Hongying Shu; Rasika Vartak; Amanda Claire Milstein; Yalin Mo; Xiaoqin Hu; Hezhi Fang; Lijun Shen; Zhinan Ding; Jianxin Lu; Yidong Bai
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.